Back
Verve Therapeutics Stock Price Chart
Groundbreaking AI Developed In Small Georgia Town Destroys Wall Street
See the remarkable discovery.
Sell
49
VERV
Verve Therapeutics
Last Price:
7.40
Seasonality Move:
-23.06%
7 Day Trial
ALL ACCESS PASS
$
7
Wall Street's Worst Nightmare: Small Town Trader's AI Edge
See the AI advantage for everyday Americans.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VERV is experiencing slight buying pressure.
Verve Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.32 | Buy |
| 20-day SMA: | 6.34 | Buy |
| 50-day SMA: | 5.8 | Buy |
| 200-day SMA: | 10.21 | Sell |
| 8-day EMA: | 7.17 | Buy |
| 20-day EMA: | 6.62 | Buy |
| 50-day EMA: | 6.48 | Buy |
| 200-day EMA: | 9.95 | Sell |
Verve Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.5 | Buy |
| Relative Strength Index (14 RSI): | 62.35 | Buy |
| Chaikin Money Flow: | 123624 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.09 - 7.13) | Buy |
| Bollinger Bands (100): | (4.56 - 10.98) | Sell |
Verve Therapeutics Technical Analysis
| Jul 12 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Verve Therapeutics Stock
Is Verve Therapeutics Stock a Buy?
- Verve Therapeutics share price is 7.48 while VERV 8-day simple moving average is 7.32, which is a Buy signal.
- The stock price of VERV is 7.48 while Verve Therapeutics 20-day SMA is 6.34, which makes it a Buy.
- Verve Therapeutics 50-day simple moving average is 5.80 while VERV share price is 7.48, making it a Buy technically.
- VERV stock price is 7.48 and Verve Therapeutics 200-day simple moving average is 10.21, creating a Sell signal.
VERV Technical Analysis vs Fundamental Analysis
Sell
49
Verve Therapeutics (VERV)
is a Sell
Is Verve Therapeutics a Buy or a Sell?
-
Verve Therapeutics stock is rated a Sell
The current Verve Therapeutics [VERV] share price is $7.48. The Score for VERV is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
Verve Therapeutics Stock Info
Market Cap:
628.06M
Price in USD:
7.48
Share Volume:
1.14M
Verve Therapeutics 52-Week Range
52-Week High:
20.98
52-Week Low:
4.59
Sell
49
Verve Therapeutics (VERV)
is a Sell
Verve Therapeutics Share Price Forecast
-
What is the Verve Therapeutics stock price today?
The Verve Therapeutics stock price is 7.48 USD today. -
Will VERV stock go up or go down?
Verve Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Verve Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Verve Therapeutics is overvalued.
Is Verve Therapeutics Stock a Buy?
- Verve Therapeutics share price is 7.48 while VERV 8-day exponential moving average is 7.17, which is a Buy signal.
- The stock price of VERV is 7.48 while Verve Therapeutics 20-day EMA is 6.62, which makes it a Buy.
- Verve Therapeutics 50-day exponential moving average is 6.48 while VERV share price is 7.48, making it a Buy technically.
- VERV stock price is 7.48 and Verve Therapeutics 200-day simple moving average is 9.95, creating a Sell signal.
Fundamental Analysis of Verve Therapeutics
Is Verve Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.64 per share, and a decrease next year of $0.25 per share.
Technical Analysis of Verve Therapeutics
Should I short Verve Therapeutics stock?
- VERV Moving Average Covergence Divergence (MACD) indicator is 0.5, suggesting Verve Therapeutics is a Buy
- Verve Therapeutics Relative Strength Index (RSI) is 62.35, which suggest Verve Therapeutics is overbought
- The Bollinger Bands (25) for Verve Therapeutics is (5.09 - 7.13), which suggest Verve Therapeutics is a Sell
- The Bollinger Bands (100) for Verve Therapeutics is (4.56 - 10.98), which suggest Verve Therapeutics is a Sell
* Verve Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.